NECA Patient Lynda Dunstone Featured in National Media on Nuclear Medicine Access
NeuroEndocrine Cancer Australia is proud to see our very own Lynda Dunstone featured in the media as part of Telix’s newly launched report on the nuclear medicines industry.
The report highlights the urgent need for greater investment, improved regulatory and reimbursement pathways, and better access to nuclear medicine imaging (PET scans) and life-changing treatments like PRRT.
Lynda’s story, included as a case study, helps shine a light on the challenges faced by neuroendocrine cancer patients and the importance of advancing theranostics in Australia.
Read more in the Daily Telegraph.
